▮ Entertainment

Top Stories
Slide Shows
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ More

Wall Street Events

Plus

Neg

Email

NuVasive Q2 19 Earnings Conference Call At 4:30 PM ET

By RTTNews Staff Writer ✉ | Published: 7/30/2019 3:00 PM ET

NuVasive, Inc. (NUVA) will host a conference call at 4:30 PM ET on July 30 2019, to discuss Q2 19 earnings results.

To access the live webcast, log on to www.nuvasive.com

For comments and feedback contact: editorial@rttnews.com

New Drugs Approved In August

New Drugs Approved In August

Biotech Stocks Facing FDA Decision In September COVID19 AML PDUFA NASH conjunctivitis seizures transplant

Biotech Stocks Facing FDA Decision In September

New Drugs Approved In July

New Drugs Approved In July

Latest Updates on COVID-19

Biden Demands Trump's Resignation Over COVID-19 Response

US 'On Track To Deliver And Distribute' COVID Vaccine In October: Trump

Europe Signs Deal With Sanofi, GSK To Secure Up To 300 Mln COVID-19 Vaccine Doses

Roche Unveils New Quantitative Antibody Test To Measure SARS-CoV-2 Antibodies

WHO Reports Biggest Daily Rise In Coronavirus Cases

Tracking Coronavirus Vaccines In Human Trials

Read More

COVID-19: Drugs in Development

RELATED NEWS

NuVasive, Inc. Q2 adjusted earnings Beat Estimates

NuVasive Q2 20 Earnings Conference Call At 4:30 PM ET

NuVasive To Report Operating Loss In Q2 - Quick Facts

Follow RTT

Editor's Pick
Most Read
Most Emailed

Walmart To Hire More Than 20,000 Seasonal Associates

TUI Warns On Weak Capacity; Cost Cutting To Likely Impact 8,000 Jobs; Stock Up

Lowe's To Install 'Buy Online Pickup In Store' Lockers At All U.S. Stores

2021 Chevrolet Silverado 1500 - Mechanical And Technological Updates

Elon Musk Says Tesla Battery Cells Won't Reach High-volume Production Until 2022

US Court Sets January Trial For Tiffany Lawsuit Against LVMH

Illumina To Acquire GRAIL In $8 Bln Cash, Stock Deal

Oracle, Walmart To Buy 20% Of TikTok Global Business

Walmart Raises Targets To Zero Emissions By 2040

Europe Signs Deal With Sanofi, GSK To Secure Up To 300 Mln COVID-19 Vaccine Doses

Acella Pharma Recalls Thyroid Drugs For Sub Potency

Walmart Raises Pay For 165,000 Hourly Associates In U.S. Stores

Europe Signs Deal With Sanofi, GSK To Secure Up To 300 Mln COVID-19 Vaccine Doses

Pre-market Movers In Healthcare Sector: ONTX, ACST, VXRT, CMPS, LPCN...

Week Ahead In Pharma: Data Readouts, FDA Decision (AQST, BCRX, ETON...)

Illumina To Acquire GRAIL In $8 Bln Cash, Stock Deal

Pre-market Movers In Healthcare Sector: IMMP, SAVA, SNOA, CRDF, INO…

Lilly, Incyte: CHMP Adopts Positive Opinion For Baricitinib In Treatment Of Atopic Dermatitis

Stock Alert: Novonix Skyrockets

Seattle Genetics, Astellas Say Phase 3 Trial Of PADCEV Meets Primary Endpoint - Quick Facts

Acella Pharma Recalls Thyroid Drugs For Sub Potency

Stock Alert: Cassava Sciences Soars 25%

CCXI To Face FDA In April, CRDF Soars On Colorectal Cancer Trial Data, VCNX In Deal With MRK

Roche Unveils New Quantitative Antibody Test To Measure SARS-CoV-2 Antibodies

Vaccinex's Phase II Study In Huntington's Disease Fails

LafargeHolcim Rebrands Blended Cement Portfolio In The U.S. - Quick Facts

GEA Sells Compressor Maker Bock To NORD Holding For Undisclosed Terms; Stock Up

Sanofi - Principia Biopharma Deal Receives U.S. Antitrust Approval

Stock Alert: Cubic Shares Surge 26%

Stock Alert: Spirit Airlines Declines 7%

Stock Alert: Legend Biotech Falls 15% As China Probes Trade Violations

Stock Alert: ROku Rises 10%

Microsoft To Acquire Bethesda Softworks Parent ZeniMax Media For $7.5 Bln In Cash

Stock Alert: Veritone Rises 13% After Receiving US Air Force Contract

Pre-market Movers In Healthcare Sector: IMMP, SAVA, SNOA, CRDF, INO…

Man Group To Buy Back Up To $100 Mln Shares - Quick Facts